Hope is growing around retatrutide, a novel dual compound targeting both GLP-1 and GIP receptors. Scientists believe this unique mechanism could offer a substantial advantage in weight loss initiatives https://adrianadbus544141.mpeblog.com/76073562/a-new-dawn-for-metabolic-management